BPH Global Reports $226K Monthly Seaweed Revenue, Secures Export Licence

Capital Raise and Financial Position

BPH Global Limited (ASX – BP8) kicked off the September quarter by successfully raising $1.1 million through a placement targeting institutional, professional, and sophisticated investors. The placement, priced at $0.002 per share, was structured in two tranches, with the first tranche already completed and the second pending shareholder approval at the upcoming annual general meeting. This capital injection bolsters the company’s cash position, which stood at approximately $619,000 at quarter-end, up from $152,000 three months prior, providing a firmer financial footing to support ongoing operations and growth initiatives.

Expanding Indonesian Seaweed Operations

Building on its June quarter momentum, BP8’s Indonesian seaweed business demonstrated sustained revenue growth through the September quarter. Monthly sales increased steadily, with revenues rising from approximately A$150,646 in May to over A$226,000 in September. The company’s vertically integrated model, combining sustainable sourcing from local Nunukan farming communities with processing and sales partnerships, notably with PT Kebula Raya Bestari, has enabled BP8 to establish a strong foothold in both domestic and international markets. A key milestone was the granting of an Indonesian Seaweed Export Licence, which authorises BP8 to export directly, streamlining access to global buyers and enhancing operational control.

Strategic Partnerships and Infrastructure Development

BP8’s recent binding commercial framework agreement with the Maluku Provisional Government marks a significant expansion of its regional supply chain. This partnership aims to secure a steady seaweed supply from Maluku province, with initial monthly targets of 200 metric tons and plans to scale to 500 metric tons. The agreement also includes collaboration on establishing a seaweed-based bio-stimulant manufacturing facility, aligning with BP8’s strategy to diversify its product offerings and deepen its presence in the agricultural sector. The company currently operates multiple warehouses in Indonesia, including a newly commissioned 550m² facility in Makassar, enhancing its processing capabilities and logistical flexibility.

Innovative R&D Progress

BP8 advanced its research and development programs with promising outcomes. The collaboration with Singapore Polytechnic culminated in the successful formulation of two probiotic green seaweed water kefir beverages, offering potential health benefits such as blood sugar management and gut microbiome support. Parallel R&D efforts with Temasek Polytechnic focus on seaweed-based bio-stimulants designed to improve crop growth and resilience, targeting key agricultural markets. Additionally, BP8’s research into seaweed’s capacity to accumulate precious and rare earth minerals opens intriguing possibilities for sustainable bioremediation and mineral recovery, with early assays confirming the presence of gold, silver, copper, and lithium in certain seaweed species.

Environmental and Market Outlook

BP8’s initiatives align closely with environmental, social, and governance (ESG) principles, leveraging seaweed’s natural benefits for ecosystem rehabilitation and sustainable agriculture. The company is actively exploring bioremediation projects in Indonesia’s mining-affected coastal areas, targeting nickel and coal sectors where pollution challenges are acute. These efforts not only support Indonesia’s environmental priorities but also position BP8 as a provider of nature-based solutions with commercial potential. Looking ahead, the company’s focus on scaling supply chains, securing additional offtake agreements, and progressing commercial partnerships will be critical to translating its operational and R&D achievements into sustained revenue growth and shareholder value.